IT1404380B1 - USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES - Google Patents
USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETESInfo
- Publication number
- IT1404380B1 IT1404380B1 ITMI2011A000213A ITMI20110213A IT1404380B1 IT 1404380 B1 IT1404380 B1 IT 1404380B1 IT MI2011A000213 A ITMI2011A000213 A IT MI2011A000213A IT MI20110213 A ITMI20110213 A IT MI20110213A IT 1404380 B1 IT1404380 B1 IT 1404380B1
- Authority
- IT
- Italy
- Prior art keywords
- complications
- diabetes
- treatment
- combination
- active ingredients
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2011A000213A IT1404380B1 (en) | 2010-02-16 | 2011-02-14 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A000236A IT1398168B1 (en) | 2010-02-16 | 2010-02-16 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES. |
ITMI2011A000213A IT1404380B1 (en) | 2010-02-16 | 2011-02-14 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20110213A1 ITMI20110213A1 (en) | 2011-08-17 |
IT1404380B1 true IT1404380B1 (en) | 2013-11-22 |
Family
ID=42270257
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2010A000236A IT1398168B1 (en) | 2010-02-16 | 2010-02-16 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES. |
ITMI2011A000213A IT1404380B1 (en) | 2010-02-16 | 2011-02-14 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2010A000236A IT1398168B1 (en) | 2010-02-16 | 2010-02-16 | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES. |
Country Status (3)
Country | Link |
---|---|
ES (1) | ES2387054B2 (en) |
FR (1) | FR2956976B1 (en) |
IT (2) | IT1398168B1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2733911B1 (en) * | 1995-05-09 | 1998-05-29 | Takeda Chemical Industries Ltd | PHARMACEUTICAL COMPOSITION FOR RENAL OR CARDIOVASCULAR DISEASES |
RU2281764C2 (en) * | 2000-03-17 | 2006-08-20 | Адзиномото Ко., Инк. | Medicinal agents for treatment of complications associated with diabetes mellitus and neuropathy and their using |
AU2581601A (en) * | 2000-12-18 | 2002-07-01 | Novartis Ag | Therapeutic combination of amlodipine and benazepril |
PE20040468A1 (en) * | 2002-05-17 | 2004-09-14 | Novartis Ag | ORGANIC COMPOUND COMBINATION |
CA2597247A1 (en) * | 2005-02-11 | 2006-08-17 | Regeneron Pharmaceuticals, Inc. | Therapeutic combination of a vegf antagonist (vegf trap) and an anti-hypertensive agent |
-
2010
- 2010-02-16 IT ITMI2010A000236A patent/IT1398168B1/en active
-
2011
- 2011-02-14 IT ITMI2011A000213A patent/IT1404380B1/en active
- 2011-02-14 ES ES201130192A patent/ES2387054B2/en active Active
- 2011-02-15 FR FR1151201A patent/FR2956976B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2387054B2 (en) | 2014-02-13 |
ITMI20100236A1 (en) | 2011-08-17 |
ES2387054A1 (en) | 2012-09-12 |
FR2956976A1 (en) | 2011-09-09 |
ITMI20110213A1 (en) | 2011-08-17 |
FR2956976B1 (en) | 2012-08-17 |
IT1398168B1 (en) | 2013-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181364T8 (en) | Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof | |
PL2731947T3 (en) | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes | |
IL231536A (en) | Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases | |
CL2014002757A1 (en) | Compounds derived from benzamide to inhibit the activity of abl1, abl2 and bcr-abl1, pharmaceutical composition; and use in the treatment of cancer. | |
CO6811867A2 (en) | Cannabinoids for use in the treatment of neuropathic pain | |
CL2014001829A1 (en) | Compounds derived from indolizine; preparation procedure; pharmaceutical compositions containing them and use in the treatment of cancer. | |
MX356957B (en) | Glucagon analogues. | |
PL2768937T3 (en) | Formulations, their use as or for the manufacture of dishwashing agents and their manufacture | |
CL2013003372A1 (en) | Compounds derived from spiro- [1,3] -oxacins and spiro- [1,4] -oxacepins, inhibitors of bace1 and / or bace2; pharmaceutical composition; procedure to prepare them; and its use in the treatment and / or prophylaxis of Alzheimer's disease and diabetes. | |
FR2975004B1 (en) | NEW ANTI-REDNESS ACTIVE INGREDIENTS AND COSMETIC COMPOSITIONS COMPRISING THE SAME | |
EP2841068B8 (en) | Crhr1 antagonists for use in the treatment of patients having crh overactivity | |
HK1201047A1 (en) | Skin care formulation | |
CL2012003322A1 (en) | Compounds derived from substituted benzamide; pharmaceutical composition; and use in the treatment of cancer. | |
IT1402082B1 (en) | INSTRUMENTS FOR THE PREPARATION OF RAVIOLI OR FILLED PASTA IN GENERAL. | |
CL2015001202A1 (en) | Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer. | |
BR112015012443A2 (en) | cleansing composition, method of cleansing the human body, use of the composition and method for providing cleansing | |
HRP20180011T1 (en) | Compounds for use in the treatment of filariasis | |
CL2014001323A1 (en) | Compounds derived from 3-phenyl-isoquinolin-1 (2h) -one, parp-1 inhibitors; preparation procedure; pharmaceutical composition; and use in the treatment of cancer. | |
CL2013001445A1 (en) | Compounds derived from diphenylamine; Pharmaceutical composition and use in the treatment of inflammatory diseases, such as cancer. | |
IT1398875B1 (en) | COMPOSITIONS CONTENTS L. MUCOSAE FOR MEDICAL USE. | |
HK1214771A1 (en) | Formulations for use in the treatment of skin conditions | |
IT1404380B1 (en) | USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES | |
CO6801770A2 (en) | Use of secnidazole in the treatment of dental infections | |
HK1172568A1 (en) | Soluble pharmaceutical forms of n,n-diaminodiphenyl sulphone for optimum use in the treatment of various diseases nn- | |
CO6801760A2 (en) | Use of 3-carboxy-n-ethyl-n, n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |